A carregar...
Androgen receptor (AR) cistrome in prostate differentiation and cancer progression
Despite the progress in development of better AR-targeted therapies for prostate cancer (PCa), there is no curative therapy for castration-resistant prostate cancer (CRPC). Therapeutic resistance in PCa can be characterized in two broad categories of AR therapy resistance: the first and most prevale...
Na minha lista:
| Publicado no: | Am J Clin Exp Urol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
e-Century Publishing Corporation
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5698595/ https://ncbi.nlm.nih.gov/pubmed/29181434 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|